These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 33580230)

  • 1. Transient editing catches the eye.
    Nat Biomed Eng; 2021 Feb; 5(2):127. PubMed ID: 33580230
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid and efficient CRISPR-mediated genome editing with cloning-free method.
    Liu W; Zhang Y; Li S; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1173-1175. PubMed ID: 30379982
    [No Abstract]   [Full Text] [Related]  

  • 3. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 4. Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
    Flotte TR; Gao G
    Hum Gene Ther; 2019 Dec; 30(12):1445-1446. PubMed ID: 31860398
    [No Abstract]   [Full Text] [Related]  

  • 5. Rock paper scissors: CRISPR/Cas9-mediated interference with geminiviruses in plants.
    Yang X; Zhou H; Zhou X
    Sci China Life Sci; 2019 Oct; 62(10):1389-1391. PubMed ID: 31571024
    [No Abstract]   [Full Text] [Related]  

  • 6. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed Evolution of CRISPR-Cas9 Base Editors.
    Winter J; Perez-Pinera P
    Trends Biotechnol; 2019 Nov; 37(11):1151-1153. PubMed ID: 31623959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sharpening the Scissors: Mechanistic Details of CRISPR/Cas9 Improve Functional Understanding and Inspire Future Research.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Sep; 140(36):11142-11152. PubMed ID: 30160947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off- and on-target effects of genome editing in mouse embryos.
    Ayabe S; Nakashima K; Yoshiki A
    J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime Time for Genome Editing?
    Urnov FD
    N Engl J Med; 2020 Jan; 382(5):481-484. PubMed ID: 31995698
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Will the CRISPR / CAS9 system change the genome of humanity?].
    Becú-Villalobos D
    Medicina (B Aires); 2017; 77(6):521-523. PubMed ID: 29223949
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
    Lombardi L; Turner SA; Zhao F; Butler G
    Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
    Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
    Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
    Muramoto T; Iriki H; Watanabe J; Kawata T
    Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbiased investigation of specificities of prime editing systems in human cells.
    Kim DY; Moon SB; Ko JH; Kim YS; Kim D
    Nucleic Acids Res; 2020 Oct; 48(18):10576-10589. PubMed ID: 32941652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.